Companies advertising their dietary supplement products in New Zealand should avoid pitfalls such as making therapeutic claims, using imagery that implies therapeutic purposes, or overpromising a health outcome.
Supplement companies in Australia will soon need to provide more details on proprietary ingredients when listing a new product or making updates to their current listing with the regulator, sparking concerns that this could negatively impact innovative...
A boysenberry and apple formulation created by Anagenix will be tested on healthy subjects with lungs damage induced by air pollution, in a new clinical trial will be conducted by New Zealand Plant & Food Research.
Australian supplement brand Nature’s Way says its toddler nutrition range Kids Smart has smashed new sales records and was the pivotal in the firm’s overall performance in this year’s Double 11 shopping event in China.
Australia’s national science agency CSIRO and vegetable producer Fresh Select have jointly established a new food manufacturing company, Nutri V who will upcycle surplus vegetables into powders and snacks.
A new Australian study has revealed that different types of whole grains have particular benefits for lowering different areas of heart disease risk – but refined grains are also still recommended as part of a balanced diet.
A series of COVID-19 related lockdowns and travel restrictions has weakened the daigou retail channel for several health and nutrition brands in Australia, with brands such as Swisse, Bubs, and Nuchev, reporting sales slumps from the once lucrative channel.
Australia’s recent bill amendment on the country-of-origin labelling will provide “long-term certainty” for supplements that meet the requirements to make the coveted ‘Made in Australia’ claim, said an industry body.
The New Zealand Hemp Industry Association (NZHIA) believes that the country “will miss the bus” if it does not start to quickly develop its cannabidiol (CBD) sector, after a new report suggesting it could become an NZD2bn industry was quickly followed...
The high frequency of vitamin C deficiency in people with respiratory infections has led researchers to call for levels to be tested on Covid-19 patients, followed by either intravenous or oral supplementation.
The Therapeutic Goods Administration (TGA) will be conducting investigations on 12 artemisia species permitted for use in the country, following scientific reports on how intake of the botanical may lead to miscarriages.